Chalasani N - Search Results

1

Relationship between resolution of non-alcoholic steatohepatitis and changes in lipoprotein sub-fractions: a post-hoc analysis of the PIVENS trial.

Corey KE, Wilson LA, Altinbas A, Yates KP, Kleiner DE, Chung RT, Krauss RM, Chalasani N; NASH Clinical Research Network. Corey KE, et al. Among authors: chalasani n. Aliment Pharmacol Ther. 2019 May;49(9):1205-1213. doi: 10.1111/apt.15216. Epub 2019 Mar 10. Aliment Pharmacol Ther. 2019. PMID: 30854694 Free PMC article. Clinical Trial.

2

Severe but reversible cholestatic liver injury after pioglitazone therapy.

Pinto AG, Cummings OW, Chalasani N. Pinto AG, et al. Among authors: chalasani n. Ann Intern Med. 2002 Nov 19;137(10):857. doi: 10.7326/0003-4819-137-10-200211190-00023. Ann Intern Med. 2002. PMID: 12435231 No abstract available.

3

Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis?

Chalasani N, Crabb DW, Cummings OW, Kwo PY, Asghar A, Pandya PK, Considine RV. Chalasani N, et al. Am J Gastroenterol. 2003 Dec;98(12):2771-6. doi: 10.1111/j.1572-0241.2003.08767.x. Am J Gastroenterol. 2003. PMID: 14687831

4

Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis.

Kessler WR, Cummings OW, Eckert G, Chalasani N, Lumeng L, Kwo PY. Kessler WR, et al. Among authors: chalasani n. Clin Gastroenterol Hepatol. 2004 Jul;2(7):625-31. doi: 10.1016/s1542-3565(04)00246-0. Clin Gastroenterol Hepatol. 2004. PMID: 15224287

5

Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes.

Vuppalanchi R, Teal E, Chalasani N. Vuppalanchi R, et al. Among authors: chalasani n. Am J Med Sci. 2005 Feb;329(2):62-5. doi: 10.1097/00000441-200502000-00002. Am J Med Sci. 2005. PMID: 15711421

6

Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study.

Vuppalanchi R, Marri S, Kolwankar D, Considine RV, Chalasani N. Vuppalanchi R, et al. Among authors: chalasani n. J Clin Gastroenterol. 2005 Mar;39(3):237-42. doi: 10.1097/01.mcg.0000152747.79773.2f. J Clin Gastroenterol. 2005. PMID: 15718867

7

Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study.

Chalasani N, Vuppalanchi R, Raikwar NS, Deeg MA. Chalasani N, et al. J Clin Endocrinol Metab. 2006 Jun;91(6):2279-85. doi: 10.1210/jc.2006-0075. Epub 2006 Apr 4. J Clin Endocrinol Metab. 2006. PMID: 16595594

8

Severe liver injury after initiating therapy with atomoxetine in two children.

Lim JR, Faught PR, Chalasani NP, Molleston JP. Lim JR, et al. J Pediatr. 2006 Jun;148(6):831-4. doi: 10.1016/j.jpeds.2006.01.035. J Pediatr. 2006. PMID: 16769398

9

Statins for hyperlipidemia in patients with chronic liver disease: are they safe?

Vuppalanchi R, Chalasani N. Vuppalanchi R, et al. Among authors: chalasani n. Clin Gastroenterol Hepatol. 2006 Jul;4(7):838-9. doi: 10.1016/j.cgh.2006.04.020. Clin Gastroenterol Hepatol. 2006. PMID: 16829348 No abstract available.

10

Multicenter timolol study: the value of timolol and hemodynamic monitoring in the management of portal hypertensive cirrhotics with no esophageal varices.

Vuppalanchi R, Chalasani N. Vuppalanchi R, et al. Among authors: chalasani n. Gastroenterology. 2006 Aug;131(2):674-6; discussion 676. doi: 10.1053/j.gastro.2006.01.090. Gastroenterology. 2006. PMID: 16890623 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

561 results

Search Page